Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tactile Systems TechnologyTCMD +0.20%74 Debt-to-Equity is 0.07 as of Mar. 2026, which is 67% below its 10-year median of 0.21. GuruFocus rates TCMD with a GF Score™ of 74/100 and a GF Value™ of $18.81 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 705 Medical Devices & Instruments companies, Tactile Systems Technology ranks better than 74.89% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Tactile Systems Technology's Debt-to-Equity or its related term are showing as below:
TCMD'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.21 Max: 0.66
Current: 0.07
During the past 13 years, the highest Debt-to-Equity Ratio of Tactile Systems Technology was 0.66. The lowest was 0.03. And the median was 0.21.
TCMD's Debt-to-Equity is ranked better than 74.89% of 705
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs TCMD: 0.07
Tactile Systems Technology (NAS:TCMD) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Tactile Systems Technology Debt-to-Equity Related Terms
Tactile Systems Technology Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TCMD vs SSII, BVS, BBNX: Debt-to-Equity Comparison
For the Medical Devices subindustry, Tactile Systems Technology's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tactile Systems Technology Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Tactile Systems Technology's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tactile Systems Technology (TCMD) has a Debt-to-Equity of 0.07 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Tactile Systems Technology and its competitors. This is 67% below median its historical median of 0.21. Over the past decade, Tactile Systems Technology's Debt-to-Equity has ranged from 0.03 to 0.66. According to the industry distribution chart, Tactile Systems Technology ranks #177 out of 705 companies in the Medical Devices & Instruments industry, placing it in the top 25.1%.
Is Tactile Systems Technology's Debt-to-Equity too high?
Tactile Systems Technology's current Debt-to-Equity of 0.07 is 67% below median its 10-year median of 0.21. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.66. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. Tactile Systems Technology's value of 0.07 is 69.6% below this industry median. Based on the distribution chart, Tactile Systems Technology ranks #177 out of 705 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Tactile Systems Technology has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tactile Systems Technology's Debt-to-Equity compare to SSII and BVS?
According to the Medical Devices & Instruments industry distribution chart, Tactile Systems Technology ranks #177 out of 705 companies for Debt-to-Equity. This puts Tactile Systems Technology in the upper half of its industry. The industry median Debt-to-Equity is 0.23. Tactile Systems Technology's value of 0.07 is 69.6% below this benchmark. Historically, Tactile Systems Technology's own Debt-to-Equity has ranged from 0.03 to 0.66 over the past decade. While the company's 10-year median is 0.21 vs. the industry median of 0.23, Tactile Systems Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tactile Systems Technology's current Debt-to-Equity of 0.07 is 69.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Tactile Systems Technology and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tactile Systems Technology's current Debt-to-Equity is 0.07, which is 67% below median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tactile Systems Technology stock overvalued right now?
Based on GuruFocus' analysis, Tactile Systems Technology (TCMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $18.81, compared to a current price of $27.50 — trading 46.2% above its estimated fair value. The current Debt-to-Equity is 0.07, which is 67% below median its 10-year median of 0.21 and 69.6% below the Medical Devices & Instruments industry median of 0.23. Tactile Systems Technology's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Tactile Systems Technology (TCMD), the current Debt-to-Equity is 0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tactile Systems Technology (TCMD) Overvalued in 2026?
Based on GuruFocus' analysis, Tactile Systems Technology stock appears to be overvalued.
The current stock price of $27.50 is trading 46.2% above its estimated GF Value™ of $18.81.
GuruFocus considers Tactile Systems Technology to be Significantly Overvalued.
Key valuation signals for TCMD:
Debt-to-Equity: 0.07 (67% below median its 10-year median of 0.21)
GF Value™: $18.81 vs. price of $27.50 (46.2% above fair value)
Industry Position: 69.6% below the Medical Devices & Instruments median (#177 of 705)
No single metric tells the full story. See the TCMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
74GF Score
Get the complete analysis for TCMD
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TCMD has been successfully added to your 
